Trastuzumab (or biosimilar) trials for Breast cancer

All Trastuzumab (or biosimilar) trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Trastuzumab (or biosimilar) for Breast cancer

• Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer
  NCT07393425 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
  NCT06649331 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
  NCT07220135 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations

Common questions

How many trials study Trastuzumab (or biosimilar) for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.